未知生产厂商
This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.
This drug has been developed using Medarex's UltiMAb Human Antibody Development System to treat autoimmune diseases.
Investigated for use/treatment in autoimmune diseases and rheumatoid arthritis.
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。